Sublime versus simple side effect stories (or, forget the adiponectin, just stop smoking). 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. July 8-11, 2003, Paris.
Mascolini
Mark
M
D052242:Adiponectin; D000273:Adipose Tissue / Q000187:drug effects; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics; D018791:CD4 Lymphocyte Count; D004268:DNA-Binding Proteins / Q000235:genetics; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007333:Insulin Resistance; D036341:Intercellular Signaling Peptides and Proteins; D008060:Lipodystrophy / Q000139:chemically induced*; D008928:Mitochondria / Q000187:drug effects; D011506:Proteins / Q000494:pharmacology; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors
D052242:Adiponectin; D019380:Anti-HIV Agents; D022762:CCAAT-Enhancer-Binding Proteins; D004268:DNA-Binding Proteins; D036341:Intercellular Signaling Peptides and Proteins; D011506:Proteins; C497387:SREBF1 protein, human; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors